Bortezomib treatment diminishes hazelnut‐induced intestinal anaphylaxis in mice

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Immunology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.201545918PMID 27111856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specialized proresolving mediators (SPMs) inhibit human B‐cell IgE production

  2016cited by this paper
• B‐cell inhibition by cross‐linking CD79b is superior to B‐cell depletion with anti‐CD20 antibodies in treating murine collagen‐induced arthritis

  2015cited by this paper
• The prevalence and distribution of food sensitization in European adults

  2014cited by this paper
• Clinical value of component‐resolved diagnostics in peanut‐allergic patients

  2013cited by this paper
• Opposing effects on immune function and skin barrier regulation by the proteasome inhibitor bortezomib in an allergen‐induced eczema model

  2013cited by this paper
• Eosinophilic oesophagitis: from physiopathology to treatment.

  2013cited by this paper
• A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.

  2013cited by this paper
• Update on risk factors for food allergy.

  2012cited by this paper
• Food-induced anaphylaxis: Clinical highlights and knowledge gaps.

  2012cited by this paper
• Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.

  2012cited by this paper
• Long-Term Bortezomib Treatment Reduces Allergen-Specific IgE but Fails to Ameliorate Chronic Asthma in Mice

  2011cited by this paper
• A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.

  2011cited by this paper
• IgE-mediated systemic anaphylaxis and impaired tolerance to food antigens in mice with enhanced IL-4 receptor signaling.

  2011cited by this paper
• Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis

  2011cited by this paper
• The Early Marginal Zone B Cell-Initiated T-Independent Type 2 Response Resists the Proteasome Inhibitor Bortezomib

  2010cited by this paper
• Effects of omalizumab in patients with food allergy.

  2010cited by this paper
• Peanut-induced intestinal allergy is mediated through a mast cell-IgE-FcepsilonRI-IL-13 pathway.

  2010cited by this paper
• Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge.

  2009cited by this paper
• Impact of native, heat‐processed and encapsulated hazelnuts on the allergic response in hazelnut‐allergic patients

  2009cited by this paper
• Mast cells and eosinophils: the two key effector cells in allergic inflammation

  2009cited by this paper
• Impairing oral tolerance promotes allergy and anaphylaxis: a new murine food allergy model.

  2009cited by this paper
• Bortezomib attenuates murine collagen-induced arthritis

  2008cited by this paper
• The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

  2008cited by this paper
• Hazelnut allergy: from pollen-associated mild allergy to severe anaphylactic reactions

  2008cited by this paper
• B cells are involved in the modulation of pathogenic gut immune response in food‐allergic enteropathy

  2008cited by this paper
• Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

  2008cited by this paper
• Bortezomib in multiple myeloma.

  2007cited by this paper
• Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells

  2007cited by this paper
• An Adjuvant-Free Mouse Model of Tree Nut Allergy Using Hazelnut as a Model Tree Nut

  2007cited by this paper
• Impact of CD40 Ligand, B Cells, and Mast Cells in Peanut-Induced Anaphylactic Responses1

  2007cited by this paper
• Competence and competition: the challenge of becoming a long-lived plasma cell

  2006cited by this paper
• Hazelnut Allergy: Evidence that Hazelnut Can Directly Elicit Specific IgE Antibody Response via Activating Type 2 Cytokines in Mice

  2005cited by this paper
• Eosinophilic gastroenteritis: A problem of the mucosal immune system?

  2003cited by this paper
• Mast cells are required for experimental oral allergen-induced diarrhea.

  2003cited by this paper
• Intestinal epithelial CD23 mediates enhanced antigen transport in allergy: evidence for novel splice forms.

  2003cited by this paper
• Enhanced transepithelial antigen transport in intestine of allergic mice is mediated by IgE/CD23 and regulated by interleukin-4.

  2001cited by this paper
• Pathogenesis and clinical features of eosinophilic esophagitis.

  2001cited by this paper
• The biology of IGE and the basis of allergic disease.

  2001cited by this paper
• A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.

  2000cited by this paper
• IgE and mast cell responses on intestinal allergen exposure: A murine model to study the onset of food allergy

  1997cited by this paper
• IgE and mast cell response on intestinal allergen exposure: a murine model to study the onset of food allergy.

  1997cited by this paper
• Cohort study of peanut and tree nut sensitisation by age of 4 years

  1996cited by this paper
• Granule chymases and the characterization of mast cell phenotype and function in rat and mouse.

  1990cited by this paper
• Food , drug , insect sting allergy , and anaphylaxis Component-resolved in vitro diagnosis of hazelnut allergy in Europe

  year unknowncited by this paper

• Crosstalk Between Allergic Inflammation and Autophagy

  2025cites this paper
• Synergistic Effects of Vitamin C Mitigates Sodium Fluoride-Induced Dental Fluorosis and Allergic Immune Responses in Mice.

  2024cites this paper
• Diversity of effects induced by boron-containing compounds on immune response cells and on antibodies in basal state.

  2021cites this paper
• Delivery of Allergen Powder for Safe and Effective Epicutaneous Immunotherapy.

  2019cites this paper
• Non-classical B Cell Memory of Allergic IgE Responses

  2019cites this paper
• Drug repurposing to treat asthma and allergic disorders: Progress and prospects

  2018cites this paper
• News & EFIS – Day of Immunology 2017

  2017cites this paper
• Outstanding animal studies in allergy I. From asthma to food allergy and anaphylaxis

  2017cites this paper
• Lifelong memory responses perpetuate humoral TH2 immunity and anaphylaxis in food allergy

  2017cites this paper